Alerts will be sent to your verified email
Verify Email
SANOFI
|
Sanofi India
|
Procter&Gamble Healt
|
Strides Pharma Scien
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Domestic Sales Growth - YoY
|
1.7 % | 20.1 % | n/a |
|
Unclassified
|
|||
|
R&D as a % of Total Sales
|
0.0 | n/a | 1.84 % |
|
Financials
|
|||
|
5 yr Average ROE
|
52.02 % | 36.03 % | 23.7 % |
|
5yr average Equity Multiplier
|
4.62 | 1.79 | 2.62 |
|
5yr Average Asset Turnover Ratio
|
0.47 | 0.77 | 0.6 |
|
5yr Avg Net Profit Margin
|
24.38 % | 19.19 % | 12.9 % |
|
Price to Book
|
12.3 | 15.91 | 3.11 |
|
P/E
|
25.62 | 32.13 | 21.54 |
|
5yr Avg Cash Conversion Cycle
|
4.83 Days | -155.74 Days | -51.45 Days |
|
Inventory Days
|
66.8 Days | 36.01 Days | 69.05 Days |
|
Days Receivable
|
31.98 Days | 40.92 Days | 60.35 Days |
|
Days Payable
|
63.37 Days | 215.28 Days | 225.58 Days |
|
5yr Average Interest Coverage Ratio
|
906.11 | 500.05 | 0.72 |
|
5yr Avg ROCE
|
27.19 % | 30.21 % | 10.5 % |
|
5yr Avg Operating Profit Margin
|
24.71 % | 27.53 % | 12.17 % |
|
5 yr average Debt to Equity
|
0.0 | 0.0 | 1.01 |
|
5yr CAGR Net Profit
|
31.63 % | 4.02 % | 68.01 % |
|
5yr Average Return on Assets
|
11.5 % | 15.5 % | 10.97 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
60.4 % | 51.82 % | 27.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 44.13 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.03 % | -3.21 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.97 % | 3.66 % | 0.16 % |
|
Sanofi India
|
Procter&Gamble Healt
|
Strides Pharma Scien
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|